|
|
|
|
About Viaxon
|
Viaxon (飛嶽山) New Drug Discovery Laboratories is spun up in 2000 from Biodyne Research Center and developes neurobehavioral and neurodegenerative therapeutics to particularly eradicate Alzheimer’s disease, Parkinson’s disease, Huntington chorea, ALS, and bipolar depression, schizophrenia, oxidative stress-associated disorders and related brain dysfunction.
Organization and research directives are shown in the following 2 diagrams.
Figure 1 The above diagram shows interrelationship among, Biodyne research Center (biodyne.com), Viaxon Drug Invention for Alzheimer’s disease and depression (viaxon.com), international on-line sales network (biopharmacy.com), anti-aging cosmetics (vivoactiv.com) and drugs (neuroactiv.com)
Figure 2 The above flow diagram of Viaxon Drug Discovery Laboratories gives the general scheme for inventing, discovering, developing new biofriendly therapeutics
|
|
|
